Items of Interest
October 12th 2021 marks the U.S. Food and Drug Administration's (FDA) first authorization for the marketing of e-cigarette products.
Use of alcohol and cannabis during adolescence is common, but what are the consequences? This review of 48 longitudinal studies describes the evidence that alcohol and cannabis use, alone or in combination, during adolescence may disrupt neural processes that are critical to the development of a healthy, adaptive brain and lead to significant deficits in learning and memory.
September is National Recovery Month. The theme for 2021 is “Recovery is For Everyone: Every Person, Every Family, Every Community”. This month, especially, we take every opportunity to increase awareness and understanding of individuals living with behavioral health conditions and celebrate those who recover.
September 9th 2021 was the deadline for FDA to decide what e-cigarettes can stay on the market, but they have delayed making a decision on Juul and other e-cigarettes. Read the full release by the FDA HERE.
The tobacco control community has been divided regarding the role of e-cigarettes in tobacco control. One study's projections show that a strategy of replacing cigarette smoking with vaping would yield substantial life year gains, even under pessimistic assumptions regarding cessation, initiation and relative harm.
E-cigarettes hold the potential to reduce cigarette smoking’s enormous toll. By itself, however, tobacco harm reduction, as embodied in vaping, is no magic bullet. A recent study reported on predicted scenarios which resulted in millions of individuals quitting smoking due to vaping.